Information  X 
Enter a valid email address

Eden Research plc (EDE)

  Print      Mail a friend       Annual reports

Wednesday 08 June, 2011

Eden Research plc

ARIPO nematode patent ? 08.06.11



                                                                             GB0001646941/GBP/PLUS-exn
                                                                                           8 June 2011

                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")

                                     Granting of nematodes patent

Eden  Research plc, a leading UK agrochemical development company, is pleased to announce the granting
of  its  'nematodes'  patent in the African Regional Industrial Property Organization  ("ARIPO").  The
patent,  which  is  for  the  use  of Eden's platform encapsulation  technology  with  terpenes  as  a
nematicide, is also in an advanced state of registration in a number of other countries. The  patented
encapsulation system itself has already been granted in a number of territories.

Nematodes  are  microscopic, soil-dwelling worms measuring approximately 0.1-5 mm in length.  Nematode
populations  can  cause  considerable  damage  to a wide  range  of  high-value  vegetable  crops  and
horticultural species.

Eden  has already licensed its nematicide product in South America to Stockton Agrimor AG and  granted
an  option  for  the product to Certis Europe BV to enter into an exclusive licence for Europe,  Asia,
Africa (excluding territories already licensed to Lachlan Kenya Limited), the Middle East and Oceania.

Clive  Newitt,  Managing  Director of Eden Research plc said, "As I  have  previously  commented,  the
nematode market has been as high as $1.1bn worldwide but due to regulatory withdrawal of many previous
products,  such  as  Temik® (aldicarb), there is a vacuum waiting to be filled by  naturally  derived,
effective, cost competitive products such as Eden's.

The  granting of this patent is clearly good news not only for Eden, but, also for both Certis  Europe
and  Lachlan  Kenya  who  will ultimately benefit from the granting of this patent  through  licensing
agreements."

The Directors of Eden are responsible for the contents of this announcement.

Enquiries:

Eden Research plc                                                                   01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                                     020 7368 6959
Mark Anwyl

Notes:

Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global
partnerships.

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk
agrochemicals.

For more information, please visit www.edenresearch.com

Eden Research plc								

						                                                                                                                                                                                                                                   

a d v e r t i s e m e n t